![Global Liquid Biopsy Market](https://res.cloudinary.com/devmoveo/image/upload/v1684747581/skyquest/gallery/Global-Liquid-Biopsy-Market.jpg)
Report ID: SQMIG35J2060
Report ID:
SQMIG35J2060 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|
Tables:
61 |
Figures:
75
In November 2023, Illumina launched an advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors. The new TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) is a research assay that enables noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) from blood when tissue testing is not available, or to complement tissue-based testing
In April 2023, QIAGEN N.V. announced the acquisition of Xylyx Bio, a developer of liquid biopsy sample preparation technologies, for $40 million
In February 2023, Bio-Rad Laboratories, Inc. announced the launch of its ddPCR liquid biopsy test for colorectal cancer diagnosis and treatment monitoring
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2060